Evidence map›Paper›PMID 35047017›Full record

ArticleFrontiers in genetics2021

Contribution of Rare and Low-Frequency Variants to Multiple Sclerosis Susceptibility in the Italian Continental Population.

Ferdinando Clarelli, Nadia Barizzone, Eleonora Mangano, Miriam Zuccalà, Chiara Basagni, Santosh Anand, Melissa Sorosina, Elisabetta Mascia, Silvia Santoro, PROGEMUS and 15 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 7 institutions in 1 country.

Ferdinando ClarelliLaboratory of Human Genetics of Neurological Disorders, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Nadia BarizzoneDepartment of Health Sciences, UPO, University of Eastern Piedmont, and CAAD (Center for Translational Research on Autoimmune and Allergic Disease), Novara, Italy.
Eleonora ManganoInstitute for Biomedical Technologies, National Research Council of Italy, Segrate, Italy.
Miriam ZuccalàDepartment of Health Sciences, UPO, University of Eastern Piedmont, and CAAD (Center for Translational Research on Autoimmune and Allergic Disease), Novara, Italy.
Chiara BasagniDepartment of Health Sciences, UPO, University of Eastern Piedmont, and CAAD (Center for Translational Research on Autoimmune and Allergic Disease), Novara, Italy.
Santosh AnandDepartment of Informatics, Systems and Communications (DISCo), University of Milano-Bicocca, Milan, Italy.
Melissa SorosinaLaboratory of Human Genetics of Neurological Disorders, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Elisabetta MasciaLaboratory of Human Genetics of Neurological Disorders, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Silvia SantoroLaboratory of Human Genetics of Neurological Disorders, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
PROGEMUS
PROGRESSO
Franca Rosa GueriniIRCCS Fondazione Don Carlo Gnocchi, Onlus, Milan, Italy.
Eleonora VirgilioDepartment of Translational Medicine, Section of Neurology and IRCAD, UNIUPO, Novara, Italy.
Antonio GalloMS Center, I Division of Neurology, Department of Advanced Medical and Surgical Sciences (DAMSS), University of Campania "Luigi Vanvitelli", Naples, Italy.
Alessandro PizzinoDepartment of Health Sciences, UPO, University of Eastern Piedmont, and CAAD (Center for Translational Research on Autoimmune and Allergic Disease), Novara, Italy.
Cristoforo ComiDepartment of Translational Medicine, Section of Neurology and IRCAD, UNIUPO, Novara, Italy.
Vittorio MartinelliNeurology Unit and Neurorehabilitation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Giancarlo ComiVita-Salute San Raffaele University, Milan, Italy.
Gianluca De BellisInstitute for Biomedical Technologies, National Research Council of Italy, Segrate, Italy.
Maurizio LeoneNeurology Unit, Fondazione IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Italy.
Massimo FilippiNeurology Unit and Neurorehabilitation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Federica EspositoLaboratory of Human Genetics of Neurological Disorders, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Roberta BordoniInstitute for Biomedical Technologies, National Research Council of Italy, Segrate, Italy.
Filippo Martinelli BoneschiDepartment of Pathophysiology and Transplantation (DEPT), Dino Ferrari Centre, Neuroscience Section, University of Milan, Milan, Italy.
Sandra D'AlfonsoDepartment of Health Sciences, UPO, University of Eastern Piedmont, and CAAD (Center for Translational Research on Autoimmune and Allergic Disease), Novara, Italy.
Vita-Salute San Raffaele University · ITUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITUniversity of Campania "Luigi Vanvitelli" · ITDon Carlo Gnocchi Foundation · ITInstitute of Biomedical Technologies · ITUniversity of Milan · ITUniversity of Milano-Bicocca · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genome-wide association studies identified over 200 risk loci for multiple sclerosis (MS) focusing on common variants, which account for about 50% of disease heritability. The goal of this study was to investigate whether low-frequency and rare functional variants, located in MS-established associated loci, may contribute to disease risk in a relatively homogeneous population, testing their cumulative effect (burden) with gene-wise tests. We sequenced 98 genes in 588 Italian patients with MS and 408 matched healthy controls (HCs). Variants were selected using different filtering criteria based on allelic frequency and

Indexed as

burden testEFCAB13multiple sclerosispool sequencingrare variants

Identifiers

PMID35047017
PMCPMC8762330
OpenAlexW4205948604

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.